MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0038 (-97.44%)
At close: Sep 17, 2025

MediXall Group Statistics

Total Valuation

MediXall Group has a market cap or net worth of 20,551. The enterprise value is 596,650.

Market Cap20,551
Enterprise Value 596,650

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date Nov 14, 2025
Ex-Dividend Date n/a

Share Statistics

MediXall Group has 205.51 million shares outstanding.

Current Share Class 205.51M
Shares Outstanding 205.51M
Shares Change (YoY) n/a
Shares Change (QoQ) +16.88%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.07
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.25
EV / Sales 1.96
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio 0.01
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.43

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -363.77%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 55.02%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count7
Asset Turnover 0.90
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.00% in the last 52 weeks. The beta is 40.41, so MediXall Group's price volatility has been higher than the market average.

Beta (5Y) 40.41
52-Week Price Change -80.00%
50-Day Moving Average 0.33
200-Day Moving Average 1.09
Relative Strength Index (RSI) 40.86
Average Volume (20 Days) 10,837

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.03

Income Statement

In the last 12 months, MediXall Group had revenue of 304,336 and -2.43 million in losses. Loss per share was -0.02.

Revenue304,336
Gross Profit -664,918
Operating Income -1.97M
Pretax Income -2.16M
Net Income -2.43M
EBITDA -1.94M
EBIT -1.97M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 31,916 in cash and 607,925 in debt, giving a net cash position of -576,009 or -0.00 per share.

Cash & Cash Equivalents 31,916
Total Debt 607,925
Net Cash -576,009
Net Cash Per Share -0.00
Equity (Book Value) -3.62M
Book Value Per Share -0.02
Working Capital -3.75M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.20M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -218.48%
Operating Margin -645.91%
Pretax Margin -710.77%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MediXall Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.83%
Shareholder Yield n/a
Earnings Yield -11,829.00%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MediXall Group has an Altman Z-Score of -296.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -296.68
Piotroski F-Score 4